About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

Newsletter

The Access Campaign Newsletters

Read, watch, share

Share the Tech - Save Lives

Newsletter |

10 September 2021

COVID-19

Share the Tech – Save Lives

No Patents Council Map 18 January 2022

Newsletter |

26 July 2021

COVID-19

Twitter storm! Tell Germany, UK and Norway to stop blocking the COVID-19 monopoly waiver!

Newsletter cover image

Newsletter |

23 July 2021

COVID-19

#NoCovidMonopolies. Thank you for helping us shape history!

In Portel, MSF teams developed activities in the rural areas where people struggle to access basic medical care. During the longest mobile clinic, through the Anapu river, activities lasted 8 days and our teams visited 4 communities. MSF treated 390 patients.

Newsletter |

22 June 2021

COVID-19

Share vaccine knowledge to save lives!

Pharma guidelines dictate that most forms of insulin must be stored in a fridge, and once opened, kept below 25°C. But MSF research shows that insulin can be stored in temperatures that reach up to 37°C and remain effective. These findings will make a huge difference to the lives of people in places like Dadaab refugee camp, Kenya, where temperatures can rocket, and not everyone has home access to a refrigerator.

Newsletter |

25 May 2021

COVID-19

100 years since insulin was discovered: why are people still waiting for treatment?

Newsletter |

03 May 2021

COVID-19

BREAKING: Join our high-level event on the WTO IP waiver

Quote comes from MSF AC Press Release from 21st April 2021, "After encouraging statement from US on landmark COVID-19 monopoly waiver, MSF calls on all opposing countries to relent ahead of next talks"

Newsletter |

22 April 2021

COVID-19

TODAY: A chance to stop COVID-19 Monopolies

In March 2017, organisations from 17 European countries filed an opposition to Gilead Science's patent on the highly effective hepatitis C drug sofosbuvir. On 13th and 14th of September 2018, the hearing took e place before the European Patent Office in Munich.

Newsletter |

24 March 2021

COVID-19

World TB Day - FB Live: A journey with a TB survivor